AUNA S.A.’s first quarter 2026 preliminary results reveal momentum in utilization and revenue growth driven by oncology expansion in Mexico and enhanced ambulatory care utilization in Peru. The company’s multi-national healthcare platform benefits from strategic public-private partnerships and diversified service lines, particularly prepaid oncology plans through Oncosalud Peru. Although liquidity remains tight, with current ratios under 1.0, AUNA manages leverage cautiously amid shareholder governance influence and regulatory challenges inherent in Latin American healthcare markets. Upcoming milestones include continued acquisition integration and evolving payer contracts that will shape near-term growth trajectories.